Our mission is to build resilience in children with or at risk of neurodevelopmental disorders through innovative biomedical interventions evaluated in real-world settings such as schools. We work to develop neurodevelopmental, resilience-building interventions and their impact within schools.

Our research team conducts clinical trials of novel pharmacologic and nutraceutical agents and brain training interventions. The team evaluates the effectiveness of these interventions in outcome studies in school settings and clinical practices. Our research involves autism, ADHD, dyslexia, depression, psychosis, and other childhood psychiatric disorders.